CCNB1 and breast cancer: Our recent study showed that CCNB1 (cyclin B1) was regulated by antitumor miR‐223‐5p in BC cells and its high expression was closely associated with poor prognosis of the patients with BC by TCGA database analysis (Sugawara et al., 2018).